Trial
NCT06351644
ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Adriana Rossi
Collaborators
—
Condition
Relapsed and/or Refractory Multiple Myeloma
Intervention
ON 123300
Why stopped
Study closure is due to insufficient supply of study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-12